TITLE

FDA Calls For Health Tests

AUTHOR(S)
Vaughan, Allyson
PUB. DATE
March 2000
SOURCE
Wireless Week;03/06/2000, Vol. 6 Issue 10, p1
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports on the National Toxicology Program test on the health effects of wireless phones recommended by the United States Food and Drug Administration (FDA). Information on a Motorola-sponsored study on the link between radio-frequency (RF) wave exposure and brain cancer; Reason for recommending the test; Reactions to the effort of the FDA to test the health effects of wireless phones.
ACCESSION #
2884806

 

Related Articles

  • FDA Will Research Phone Use.  // Wireless Week;06/12/2000, Vol. 6 Issue 24, p1 

    Reports on the agreement between CTIA and the United States Food and Drug Administration for research into the possible health effects of wireless phone use.

  • FDA approves wireless heart monitor.  // RCR Wireless News;1/7/2002, Vol. 21 Issue 1, p37 

    Reports on the approval of the United States Food and Drug Administration on CareLink, a wireless system that allows doctors to view data from defibrillators implanted in heart patients' chest via the Internet developed by Medtronic Inc. Medtronic patients to be affected by the approval.

  • Markey, FDA agree on need for RF studies, no hint of next step. Silva, Jeffrey // RCR;05/12/97, Vol. 16 Issue 19, p3 

    Reports that the Food and Drug Administration ,and Representative Edward Markey, have agreed that studies of radio frequency radiation in regards to cellular telephones, be conducted. Factors prompting the necessity of these studies; Health risks associated with the use of cellular phones;...

  • Final RF device guidance out, but some firms still not ready. McCARTY, MARK // Medical Device Daily;8/19/2013, Vol. 17 Issue 159, p1 

    The article focuses on the final guidance, published by the U.S. Food and Drug Administration (FDA), that deals with devices enabled for radio-frequency communication. The final guidance addressed several issues, including the implications of repeated device failures at the same facility or in...

  • FDA gives green light for AVIVO cardio-monitoring by Corventis. FORD, OMAR // Diagnostics & Imaging Week;5/7/2009, Vol. 12 Issue 18, p1 

    The article reports on the clearance received by Corventis from the U.S. Food and Drug Administration (FDA) for its AVIVO Mobile Patient Management System. The non-invasive, wireless system is capable of monitoring cardiovascular conditions. According to Corventis, the product is a platform...

  • RETHINKING THE FDA'S REGULATION OF MOBILE MEDICAL APPS. Danzis, Scott D.; Pruitt, Christopher // SciTech Lawyer;Winter/Spring2013, Vol. 9 Issue 3/4, p27 

    The article focuses on the role of mobile devices in health care system. It states that the authority of the U.S. Food and Drug Administration (FDA) has to regulate applications as medical devices due to growing importance of mobile applications and other software in health care. It further...

  • Health Debate Showdown. Carlson, Caron // Wireless Week;10/25/99, Vol. 5 Issue 43, p1 

    Focuses on the plan of the United States (US) Federal Communications Commission to conduct its own handset tests for bioeffects of wireless devices. What prompted the commission to conduct handset tests; Cause of criticism to the commission's handset authorization process; Role of the US Food...

  • FDAer hints agency concerned about fail-safe wireless health. McCARTY, MARK // Medical Device Daily;4/29/2011, Vol. 15 Issue 83, p1 

    The article discusses issues about emerging wireless telehealth devices that concern developers, regulators and users. Associate director for technology and innovation Jonathan Sackner-Bernstein of the U.S. Food and Drug Administration's Center for Devices and Radiological Health (CDRH) advises...

  • Regulating medical apps: which ones and how much? Kamerow, Douglas // BMJ: British Medical Journal;10/19/2013, Vol. 347 Issue 7929, p24 

    The author discusses the U.S. Food and Drug Administration's (FDA) guidelines on the use of medical applications and mobile medical devices. The FDA defined mobile medical application as a software application run on a mobile platform. Health related applications are classified as non-devices...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics